You have 9 free searches left this month | for more free features.

City

Tempe (2)

Baltimore (1)

Canberra (1)

Kanwal (1)

Kippa-Ring (1)

Melbourne (1)

Sydney (1)

Condition

Gout (5)

Hyperuricemia (3)

Food-drug Interaction (1)

Overall Status

Completed (3)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. (5)

Collaborator

Intervention

abp-671 (5)

placebo (4)

allopurinol (1)

Study Documents

Intervention Type

drug (5)

other (3)

Funder Type

Industry (5)

Study Type

Interventional (5)

abp-671

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gout Trial (ABP-671, Allopurinol, Placebo)

Not yet recruiting

Gout

ABP-671
+2 more

(no location specified)

Apr 5, 2023

Gout, Hyperuricemia Trial in Australia (ABP-671, Placebo)

Recruiting

Gout
Hyperuricemia

ABP-671
Placebo

Canberra, Australia
+4 more

Nov 16, 2020

Gout, Hyperuricemia Trial in Tempe (ABP-671, Placebo)

Completed

Gout
Hyperuricemia

ABP-671
Placebo

Tempe, Arizona

Celerion

Jul 27, 2020

Gout, Food-drug Interaction Trial in Baltimore (ABP-671)

Completed

Gout
Food-drug Interaction

ABP-671

Baltimore, Maryland

Pharmaron CPC, Inc.

Jun 22, 2020

Hyperuricemia, Gout Trial in Tempe (ABP-671, Placebo)

Completed

Hyperuricemia
Gout

ABP-671
Placebo

Tempe, Arizona

Celerion

Feb 10, 2020